Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort
about
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancerMicroRNAs as growth regulators, their function and biomarker status in colorectal cancer2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsEpigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapseTissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer - a meta-analysisThe prognostic yield of biomarkers harvested in chemotherapy-naive stage II colon cancer: can we separate the wheat from the chaff?Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway.The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3β/E-cadherin pathway.MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer.Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer.
P2860
Q26774690-2C840F21-222B-4DF2-9404-734B6E524833Q26775610-AD860C97-5590-436A-8368-D4B8459A8E8FQ30239808-1BC142A5-F882-4ACD-8278-70D6682F5F7CQ34487177-2D51CF68-E248-4BAD-A3A0-E37EE75E71A5Q35021086-D4F96EF8-EF74-48A0-9DDB-AA5000F9B39CQ36029900-28AEE387-309C-4038-AF98-3EA8527A9637Q37256316-2CCE8CDE-E958-47FF-B845-45679B0DF6B4Q37349280-DFD32C83-E1C1-4872-B025-C777FC52AD37Q39246347-42E3B99B-9A3F-4F0B-AFED-C6252CA6F208Q41472574-192A9A83-F1A8-4FC6-B988-BE57D9F6EF46Q48310742-CDC30663-6FC3-40EF-B374-3FB09441E812Q52579497-90788327-6A7E-4FA0-9A67-41A9AF9FA477Q55361312-7DD471E1-EFA5-45CB-9278-536214994AF5
P2860
Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Redefining high-risk patients ...... from a population-based cohort
@ast
Redefining high-risk patients ...... from a population-based cohort
@en
Redefining high-risk patients ...... from a population-based cohort
@nl
type
label
Redefining high-risk patients ...... from a population-based cohort
@ast
Redefining high-risk patients ...... from a population-based cohort
@en
Redefining high-risk patients ...... from a population-based cohort
@nl
prefLabel
Redefining high-risk patients ...... from a population-based cohort
@ast
Redefining high-risk patients ...... from a population-based cohort
@en
Redefining high-risk patients ...... from a population-based cohort
@nl
P2093
P2860
P50
P356
P1476
Redefining high-risk patients ...... from a population-based cohort
@en
P2093
J Lindebjerg
R D Christensen
S Kjær-Frifeldt
S Morgenthaler
P2860
P2888
P304
P356
10.1038/BJC.2014.409
P407
P577
2014-07-22T00:00:00Z
P5875
P6179
1013055645